Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 78

1.

Effect of Telmisartan or Losartan for Treatment of Nonalcoholic Fatty Liver Disease: Fatty Liver Protection Trial by Telmisartan or Losartan Study (FANTASY).

Hirata T, Tomita K, Kawai T, Yokoyama H, Shimada A, Kikuchi M, Hirose H, Ebinuma H, Irie J, Ojiro K, Oikawa Y, Saito H, Itoh H, Hibi T.

Int J Endocrinol. 2013;2013:587140. doi: 10.1155/2013/587140. Erratum in: Int J Endocrinol. 2014;2014:302602. Dosage error in published abstract; MEDLINE/PubMed abstract corrected.

2.

Effects of telmisartan and losartan on insulin resistance in hypertensive patients with metabolic syndrome.

Bahadir O, Uzunlulu M, Oguz A, Bahadir MA.

Hypertens Res. 2007 Jan;30(1):49-53. Erratum in: Hypertens Res. 2007 Jun;30(6):573.

PMID:
17460371
4.

Metabolic effect of telmisartan and losartan in hypertensive patients with metabolic syndrome.

Vitale C, Mercuro G, Castiglioni C, Cornoldi A, Tulli A, Fini M, Volterrani M, Rosano GM.

Cardiovasc Diabetol. 2005 May 15;4:6.

5.

Efficacy and safety of telmisartan vs. losartan in control of mild-to-moderate hypertension: a multicentre, randomised, double-blind study.

Zhu JR, Bai J, Cai NS, Tang B, Fan WH, Guo JZ, Ke YN, Guo JX, Sheng LH, Lu ZY, Cheng NN.

Int J Clin Pract Suppl. 2004 Dec;(145):46-9.

PMID:
15617459
6.
7.

Systematic review of the effect of telmisartan on insulin sensitivity in hypertensive patients with insulin resistance or diabetes.

Suksomboon N, Poolsup N, Prasit T.

J Clin Pharm Ther. 2012 Jun;37(3):319-27. doi: 10.1111/j.1365-2710.2011.01295.x. Review.

PMID:
21848583
8.

A double-blind comparison of the efficacy and tolerability of telmisartan 40-80 mg vs. losartan 50-100 mg in Taiwanese hypertensive patients.

Lee YT, Lee CM, Lin CS, Sheu SH, Kuo WK, Tsai CW, Huang LC, Huang HC, Wang JS, Tseng WK.

Int J Clin Pract Suppl. 2004 Dec;(145):40-5.

PMID:
15617458
10.

Anti-albuminuric effect of losartan versus amlodipine in hypertensive Japanese patients with type 2 diabetes mellitus: A prospective, open-label, randomized, comparative study.

Ohno Y, Nishimura A, Iwai H, Hirota N, Yamauchi T, Fujimoto M, Miyatake T, Arai H, Aoki N.

Curr Ther Res Clin Exp. 2007 Mar;68(2):94-106. doi: 10.1016/j.curtheres.2007.04.002.

11.

Differential response of vascular hepatocyte growth factor concentration and lipid accumulation between telmisartan and losartan in ApoE-deficient mice.

Nakagami H, Osako MK, Takami Y, Hanayama R, Koriyama H, Mori M, Hayashi H, Shimizu H, Morishita R.

Mol Med Rep. 2008 Sep-Oct;1(5):657-61. doi: 10.3892/mmr_00000008.

PMID:
21479465
12.

Comparison of the effects of three angiotensin II receptor type 1 blockers on metabolic parameters in hypertensive patients with type 2 diabetes mellitus.

Ozaki N, Nomura Y, Sobajima H, Kondo K, Oiso Y.

Eur J Intern Med. 2010 Jun;21(3):236-9. doi: 10.1016/j.ejim.2010.01.014.

PMID:
20493430
13.

Effects of a low-dose antihypertensive diuretic in combination with losartan, telmisartan, or candesartan on serum urate levels in hypertensive patients.

Hamada T, Mizuta E, Kondo T, Hirai M, Yamada K, Kato M, Shigemasa C, Yamamoto Y, Ninomiya H, Igawa O, Hisatome I.

Arzneimittelforschung. 2010;60(2):71-5. doi: 10.1055/s-0031-1296251.

PMID:
20329654
14.

Telmisartan improves vascular function independently of metabolic and antihypertensive effects in hypertensive subjects with impaired glucose tolerance.

Perl S, Schmölzer I, Sourij H, Pressl H, Eder M, Zweiker R, Wascher TC.

Int J Cardiol. 2010 Mar 18;139(3):289-96. doi: 10.1016/j.ijcard.2008.10.048.

PMID:
19118910
15.

[Therapeutic effects of insulin-sensitizing drugs on nonalcoholic fatty liver disease: experiment with rats].

Zhang DM, Zhang GY, Wang T, Zhong HJ, Chen WK.

Zhonghua Yi Xue Za Zhi. 2006 May 16;86(18):1279-83. Chinese.

PMID:
16796890
17.
18.

Telmisartan at 80 mg/day increases high-molecular-weight adiponectin levels and improves insulin resistance in diabetic patients.

Mori H, Okada Y, Arao T, Nishida K, Tanaka Y.

Adv Ther. 2012 Jul;29(7):635-44. doi: 10.1007/s12325-012-0032-x.

PMID:
22821644
Items per page

Supplemental Content

Support Center